Editas Medicine, Inc.
EDIT
$2.65
$0.010.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -344.52% | 77.62% | 52.82% | 30.03% | -67.61% |
| Total Depreciation and Amortization | -40.00% | 11.65% | -60.69% | -4.33% | -39.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.30% | -64.07% | -21.42% | -33.66% | 145.91% |
| Change in Net Operating Assets | 94.44% | -201.60% | -138.35% | -126.23% | 245.59% |
| Cash from Operations | 36.62% | -17.97% | 38.57% | -5.05% | 5.84% |
| Capital Expenditure | -53.33% | 86.14% | -- | 100.00% | 78.89% |
| Sale of Property, Plant, and Equipment | 32.20% | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -5.87% | -24.78% | 79.38% |
| Cash from Investing | 10.34% | -99.85% | -7.21% | -24.36% | 82.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.91% | 131.64% | 416.52% | 433.46% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -105.20% |
| Cash from Financing | -- | 0.91% | 131.64% | 615.80% | -102.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.02% | -173.37% | 17,366.00% | -102.10% | -79.97% |